Seymour LW - Search Results

1

Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.

Su W, Patrício MI, Duffy MR, Krakowiak JM, Seymour LW, Cawood R. Su W, et al. Among authors: seymour lw. Nat Commun. 2022 Mar 7;13(1):1182. doi: 10.1038/s41467-022-28738-2. Nat Commun. 2022. PMID: 35256603 Free PMC article.

2

Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera.

Carlisle RC, Benjamin R, Briggs SS, Sumner-Jones S, McIntosh J, Gill D, Hyde S, Nathwani A, Subr V, Ulbrich K, Seymour LW, Fisher KD. Carlisle RC, et al. Among authors: seymour lw. J Gene Med. 2008 Apr;10(4):400-11. doi: 10.1002/jgm.1161. J Gene Med. 2008. PMID: 18220318

3

Toward more effective gene delivery.

Chen HH, Cawood R, Seymour LW. Chen HH, et al. Among authors: seymour lw. Genome Biol. 2008 Jan 18;9(1):301. doi: 10.1186/gb-2008-9-1-301. Genome Biol. 2008. PMID: 18226177 Free PMC article.

4

Cellular carriers or free viruses?

Seymour LW, Cawood R, Fisher KD. Seymour LW, et al. Curr Opin Mol Ther. 2008 Aug;10(4):321-2. Curr Opin Mol Ther. 2008. PMID: 18683095 No abstract available.

5

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.

Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, Seymour LW. Cawood R, et al. Among authors: seymour lw. PLoS Pathog. 2009 May;5(5):e1000440. doi: 10.1371/journal.ppat.1000440. Epub 2009 May 22. PLoS Pathog. 2009. PMID: 19461878 Free PMC article.

6

Blood compatibility of enveloped viruses.

Kueberuwa G, Cawood R, Seymour LW. Kueberuwa G, et al. Among authors: seymour lw. Curr Opin Mol Ther. 2010 Aug;12(4):412-20. Curr Opin Mol Ther. 2010. PMID: 20677092 Review.

7

Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.

Chen HH, Cawood R, El-Sherbini Y, Purdie L, Bazan-Peregrino M, Seymour LW, Carlisle RC. Chen HH, et al. Among authors: seymour lw. Mol Ther. 2011 Jan;19(1):67-75. doi: 10.1038/mt.2010.209. Epub 2010 Sep 28. Mol Ther. 2011. PMID: 20877345 Free PMC article.

8

MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.

Cawood R, Wong SL, Di Y, Baban DF, Seymour LW. Cawood R, et al. Among authors: seymour lw. PLoS One. 2011 Jan 10;6(1):e16152. doi: 10.1371/journal.pone.0016152. PLoS One. 2011. PMID: 21264344 Free PMC article.

9

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway.

Seki T, Carroll F, Illingworth S, Green N, Cawood R, Bachtarzi H, Subr V, Fisher KD, Seymour LW. Seki T, et al. Among authors: seymour lw. J Control Release. 2011 Dec 20;156(3):381-9. doi: 10.1016/j.jconrel.2011.08.022. Epub 2011 Aug 22. J Control Release. 2011. PMID: 21884739

10

Virotherapy--cancer targeted pharmacology.

Tedcastle A, Cawood R, Di Y, Fisher KD, Seymour LW. Tedcastle A, et al. Among authors: seymour lw. Drug Discov Today. 2012 Mar;17(5-6):215-20. doi: 10.1016/j.drudis.2011.12.011. Epub 2011 Dec 16. Drug Discov Today. 2012. PMID: 22198165 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters